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A B S T R A C T
Objectives: To investigate whether live birth (LB) is associated with oocyte yield and number of biopsied
and suitable blastocyst to transfer following preimplantation genetic testing (PGT) for monogenic
disorders (PGT-M) and chromosomal structural rearrangements (PGT-SR).
Study design: All couples underwent controlled ovarian stimulation, blastocyst biopsy, vitriﬁcation and
transfer of suitable embryo(s) in a frozen embryo transfer (FET) cycle.
Results: Of 175 couples who underwent PGT treatment, 249 oocytes retrievals were carried out and 230
FET were subsequently undertaken. 122/230 (53%, 95% CI 47–59) FET resulted in a LB and 16/230 (7%, 95%
CI 4–11) have resulted in ongoing pregnancies. 21/230 (9%, 95% CI 6–14) FET resulted in miscarriage and
69/230 (30%, 95% CI 24–36) concluded with failed implantation. Two (1%, 95% CI 0–3) transfers
underwent termination for congenital malformation, with no evidence of misdiagnosis by prenatal
testing. The relationship between number of oocytes retrieved and number of blastocysts biopsied and
suitable embryos to transfer were signiﬁcant (p = 0.00; Incidence rate ratio (IRR) 1.05; 95% 1.04–1.06;
p = 0.00; IRR 1.04; 95%, 1.03–1.06), respectively. The number of oocytes collected (p = 0.007; OR 1.06; 95%
CI 1.01–1.10), the number of blastocysts biopsied (p = 0.001; OR 1.14; 95% 95% CI 1.06–1.23) and the
number of suitable embryos to transfer (p = 0.00; OR 1.38; 95% CI 1.17–1.64) were all signiﬁcantly
associated with the odds of achieving a LB. There is a 14% and 38% increased chance of a LB per additional
blastocyst biopsied and suitable embryo to transfer, respectively.
Conclusions: PGT-M and PGT-SR outcomes are signiﬁcantly associated with egg yield, number of
blastocysts to biopsy and suitable embryos to transfer.
© 2019 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Preimplantation genetic testing (PGT) for monogenic disorders
(PGT-M) or chromosomal structural rearrangements (PGT-SR) is an
alternative to prenatal diagnosis for couples who are inherently
predisposed to the transmission of a genetic disorder to their
offspring. If couples decide to utilise PGT, it necessitates the use of* Corresponding author.
E-mail address: jara.bennagi@crgh.co.uk (J. Ben-Nagi).
http://dx.doi.org/10.1016/j.eurox.2019.100055
2590-1613/© 2019 The Authors. Published by Elsevier B.V. This is an open access article un
Please cite this article in press as: J. Ben-Nagi, et al., Live birth rate is 
blastocysts to transfer in preimplantation genetic testing (PGT) cycles for
Eur J Obstet Gynecol (2019), http://dx.doi.org/10.1016/j.eurox.2019.1000in vitro fertilisation (IVF), regardless of fertility, to produce
embryos to biopsy.
In IVF cycles, it has been shown that there is a strong
correlation between the number of oocytes retrieved and live
birth rate [1]. As such the number of oocytes can be used as a
robust surrogate outcome for clinical success. Although the
relationship is not linear, the live birth rate rises with increasing
number of oocytes retrieved, up to 15. For successful PGT
outcome, it has also been demonstrated that the number of
cumulus oocyte complex is signiﬁcantly associated with the
number of embryos biopsied, and the number of suitable embryos
to transfer [2].der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
associated with oocyte yield and number of biopsied and suitable
 monogenic disorders and chromosomal structural rearrangements,
55
2 J. Ben-Nagi et al. / European Journal of Obstetrics & Gynecology and Reproductive Biology: X xxx (2019) 100055
G Model
EUROX 100055 No. of Pages 6With extended embryo culture resulting in increased rates of
blastocyst formation, blastocyst biopsy has been successfully
performed in PGT cycles [3,4]. Retrieval of three to six trophecto-
derm cells from a blastocyst compares more favorably to the
removal of 1–2 cells from a cleavage-stage embryo. In a paired
randomized clinical trial, day-3 embryo biopsy led to 30%
implantation and live birth, in comparison to 50% for unbiopsied
controls, which represents a relative reduction of 39% [5]. In
contrast, implantation rates were similar for biopsied and control
blastocysts [5].
Furthermore, following the advent of vitriﬁcation for cryopres-
ervation of embryos, recent systematic reviews and randomized
controlled trials have indicated comparable or improved pregnan-
cy rates with frozen embryo transfer compared with fresh embryo
transfer [6,7]. Hence, IVF centres carrying out PGT-M, PGT-SR and
preimplantation genetic testing for aneuploidies (PGT-A) have
adopted this strategy of blastocyst biopsy, cryopreservation and
frozen embryo transfer for PGT cases.
To the best of our knowledge, there has not yet been published
data to investigate the association between oocyte and blastocyst
yield with live birth rate in PGT-M and PGT-SR cycles. The aim of
this study was to provide evidence that live birth rate in PGT-M and
PGT-SR cycles is associated with the number of oocytes retrieved,
blastocysts biopsied and suitable embryos available for transfer.
This evidence can assist reproductive medicine specialists and
embryologists in counselling women, in order to identify the
oocyte and blastocyst thresholds that increase the probability of
live birth following PGT.
Material and methods
Patient selection
All couples referred to the IVF Centre for PGT-M and PGT-SR
over a four-year period between 2014 and 2017 were included in
the study. Following a detailed assessment of the genetic history it
was determined whether Karyomapping or array comparative
genomic hybridisation (a-CGH) was possible for monogenic or
chromosomal rearrangement, respectively.
For PGT-M, the Karyomapping method adopted has been
previously described by Natesan et al. [8] and Konstantinidis et al.
[9]. Karyomapping was also able to detect chromosomal aneu-
ploidies in the tested embryos that were subsequently considered
for transfer. Whilst for PGT-SR, a-CGH has been described
elsewhere [10,11] and implemented in the current study.
IVF, blastocyst biopsy and embryo transfer
IVF was commenced once the PGT-M workup was complete for
single gene disorder or the genetic laboratory was able to identify
the chromosomal rearrangement with a diagnostic accuracy of
more than 95% for PGT-SR. All couples underwent controlledTable 1
PGT cycle laboratory outcomes and embryo biopsy results.
PGT cycle characteristics 
No. of oocytes 
No. of metaphase II oocytes 
Fertilisation rate 
Blastulation rate 
Proportion of blastocysts for monogenic disorders (%) 
Proportion of blastocysts for chromosomal rearrangement (%) 
Proportion of blastocysts suitable for transfer (%) 
Proportion of blastocysts unsuitable for transfer (%) 
Proportion of blastocysts unaffected but aneuploid (%) 
PGT = preimplantation genetic testing cycle; No.: number; N/A: not applicable.
Please cite this article in press as: J. Ben-Nagi, et al., Live birth rate is 
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Eur J Obstet Gynecol (2019), http://dx.doi.org/10.1016/j.eurox.2019.1000ovarian stimulation, blastocyst biopsy, vitriﬁcation and subse-
quent medicated frozen embryo replacement cycle, which has
been previously described [12].
Ethics
All patients received genetic counselling. The IVF process
including PGT was explained in detail to ensure that all couples
were fully informed. Written consent was received for IVF and PGT.
No embryo was subjected to research. Thus, this retrospective case
series was exempt from ethical approval.
Statistics
Descriptive statistical analysis was described as mean +/ SD.
Logistic regression analysis was performed, to evaluate either the
probability of a live birth or the probability of at least one suitable
embryo when the explanatory/independent variable was either
the total number of oocytes, the number of blastocysts or the
number of suitable embryos, as appropriate. Age in years was
included as an additional explanatory variable in these logistic
regression analyses. A receiver operating characteristic (ROC)
curve was plotted giving an indication of the diagnostic ability of
the explanatory variable in the logistic regression to discriminate
between a binary outcome/dependent variable of “live birth” (yes/
no) or of “at least one suitable embryo” (yes/no) as its threshold
varied. The area under the ROC curve was evaluated to measure
how well the explanatory variable distinguished between the two
diagnostic groups [e.g. live birth (yes/no)]. Poisson regression was
used to evaluate the effect of the number of oocytes retrieved
either on the number of blastocysts biopsied or on the number of
suitable embryos to transfer, again using age in years as a covariate.
All analyses were performed using Stata (StataCorp). 2017. Stata
Statistical Software: Release 15. College Station, TX: StataCorp LLC)
and statistical signiﬁcance was achieved if p < 0.05.
Results
175 couples underwent PGT. 145 (83%) couples had PGT-M
whilst 30 (17%) had PGT-SR. 44 (25%) couples had a second or third
cycles. 17 (10%) couples underwent embryo batching in order to
maximise their egg yield and blastocyst formation rate in view of
diminished ovarian reserve and/or previous low response to
controlled ovarian stimulation. 249 oocyte retrievals were carried
out; 196 (79%) because of single gene disorders and 53 (21%) for
chromosomal rearrangement. The mean female age was 33.9 years
(SD  3.8). Table 1 shows PGT cycle laboratory outcomes and
embryo biopsy results.
A total of 230 frozen embryo transfers were carried out. 122
(53%, 95% CI 47–59) resulted in a live birth and 16 (7%, 95% CI 4–11)
have ongoing pregnancies. 21 (9%, 95% CI 6–14) frozen embryo
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Fig. 2. Graph showing the probability of having at least one suitable embryo to
transfer against the number of blastocysts biopsied.
Fig. 3. Graph showing the probability of achieving a live birth against number of
oocytes retrieved.
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resulted in termination for congenital malformation, with no
evidence of misdiagnosis by pre-natal testing.
Whole group analysis
The relationship between the number of oocytes retrieved and
number of blastocysts biopsied, after adjusting for age in years, was
signiﬁcant (p = 0.00; Incidence rate ratio (IRR) 1.05; 95% 1.04–1.06).
Similarly, there was a signiﬁcant relationship between number of
oocytes retrieved and the number of suitable embryos to transfer
(p = 0.00; IRR 1.04; 95%, 1.03–1.06). Fig. 1 demonstrates the
probability of at least one suitable embryo against the number
of oocytes retrieved.
The number of blastocysts biopsied was signiﬁcantly associated
with the odds of at least one suitable embryo (p = 0.00; OR 1.61;
95% CI 1.35–1.95) (Fig. 2). The area under the ROC curve was 0.80
indicating a good discriminating power to predict the odds of at
least one suitable embryo with increasing number of blastocysts
biopsied.
The total number of oocytes collected was signiﬁcantly
associated with the odds of a live birth (p = 0.007; OR 1.06; 95%
CI 1.01–1.10) (Fig. 3). The area under ROC curve was 0.59 for the
total number of oocytes collected when the binary outcome of
interest was whether or not the woman had a live birth.
The total number of blastocysts biopsied was signiﬁcantly
associated with the odds of a live birth (p = 0.001; OR 1.14; 95% 95%
CI 1.06–1.23).The number of suitable embryos was also signiﬁ-
cantly associated with the odds of a live birth (p = 0.00; OR 1.38;
95% CI 1.17–1.64) (Fig. 4). The area under ROC curve was 0.71, which
indicates the number of suitable embryos has a moderate
discriminating power to identify women who will have a live birth.
Table 2 summarises the inter-relationships between age and
associations between number of oocytes retrieved, blastocysts
biopsied, suitable embryos to transfer and odds of a live birth for
the whole group, single gene and chromosomal rearrangement
group.
Single gene disorders
On further analysis of couples embarking on PGT-M, the
number of oocytes retrieved was a signiﬁcant predictor of the
number of blastocysts biopsied (p = 0.00; IRR 1.05; 95% CI 1.04–
1.05). There was also a signiﬁcant association between the number
of oocytes retrieved and number of suitable embryos obtained
(p = 0.00; IRR 1.04; 95% CI 1.03–1.05).Fig. 1. Graph showing the probability of having at least one suitable embryo to
transfer against the number of oocytes collected.
Fig. 4. Graph showing the probability of live birth against number of suitable
embryos to transfer.
Please cite this article in press as: J. Ben-Nagi, et al., Live birth rate is 
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(Fig. 5) and the number of blastocysts biopsied (p = 0.01; OR 1.12;
95% CI 1.03–1.22) (Fig. 6) had a signiﬁcant effect on the odds of a
live birth. The number of suitable embryos obtained also had a
signiﬁcant effect on the odds of a live birth (p = 0.004; OR 1.28; 95%
CI 1.08–1.51) (Fig. 7).associated with oocyte yield and number of biopsied and suitable
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Table 2
Inter-relationships between age and associations between number of oocytes retrieved, blastocysts biopsied, suitable embryos to transfer and odds of a live birth.
Age
P value IRR / OR 95% CI
Whole group Oocytes retrieved vs Blastocysts biopsied 0.035 0.98 (IRR) 0.97-0.99
Oocytes retrieved vs Suitable embryos to transfer 0.001 0.94 (IRR) 0.92-0.96
Blastocysts biopsied vs Suitable embryos to transfer 0.002 0.85 (OR) 0.76 – 0.94
Oocytes retrieved vs Odds of live birth 0.22 0.96 (OR) 0.89-1.03
Blastocysts biopsied vs Odds of live birth 0.347 0.97 (OR) 0.90 – 1.04
Suitable embryos vs Odds of live birth 0.76 0.99 (OR) 0.92 – 1.06
Single gene disorders Oocytes retrieved vs Blastocysts biopsied 0.12 0.99 (IRR) 0.97 – 1.00
Oocytes retrieved vs Suitable embryos to transfer 0.00 0.95 (IRR) 0.93-0.98
Blastocysts biopsied vs Suitable embryos to transfer 0.001 0.96 (IRR) 0.95-0.98
Oocytes retrieved vs Odds of live birth 0.45 0.97 (OR) 0.90-1.05
Blastocysts biopsied vs Odds of live birth 0.57 0.98 (OR) 1.02-1.21
Suitable embryos vs Odds of live birth 0.89 0.99 (OR) 0.92-1.08
Chromosomal rearrangements Oocytes retrieved vs Blastocysts biopsied 0.27 0.98 (IRR) 0.94-1.02
Oocytes retrieved vs Suitable embryos to transfer 0.01 0.90 (IRR) 0.83-0.98
Blastocysts biopsied vs Suitable embryos to transfer 0.009 0.68 (OR) 0.52-0.91
Oocytes retrieved vs Odds of live birth 0.45 0.93 (OR) 0.78-1.11
Blastocysts biopsied vs Odds of live birth 0.57 0.95 (OR) 0.79-1.14
Suitable embryos vs Odds of live birth 0.68 1.05 (OR) 0.84 – 1.30
CI; Conﬁdence Interval, IRR; Incidence rate ratio, OR; Odds Ratio.
Bold values: Level of signiﬁcance if p < 0.05.
Fig. 5. Graph showing the probability of having a live birth against the number of
oocytes retrieved in patients undergoing PGT-M.
Fig. 6. Graph showing the probability of having a live birth against the number of
blastocyst biopsied in patients undergoing PGT-M.
Fig. 7. Graph showing the probability of having a live birth against the number of
suitable embryos to transfer in patients undergoing PGT-M.
Fig. 8. Graph showing the probability of having at least one suitable embryo to
transfer in patients undergoing PGT-SR against the total number of oocytes
retrieved.
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Fig. 9. Graph showing the relationship between the probability of having at least
one suitable embryo to transfer in patients undergoing PGT-SR against the number
of blastocysts biopsied.
Fig. 10. Graph showing the probability of having a livebirth against the number of
oocytes retrieved in patients undergoing PGT-SR.
Fig. 11. Graph showing the relationship between the probability of a live birth and
the number of suitable embryos in patients undergoing PGT-SR.
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For couples embarking on PGT-SR, the total number of oocytes
retrieved was a signiﬁcant predictor of the number of blastocysts
biopsied (p = 0.00; IRR 1.09; 95% CI 1.07–1.11). The total number of
oocytes collected was a signiﬁcant predictor of whether there wasPlease cite this article in press as: J. Ben-Nagi, et al., Live birth rate is 
blastocysts to transfer in preimplantation genetic testing (PGT) cycles for
Eur J Obstet Gynecol (2019), http://dx.doi.org/10.1016/j.eurox.2019.1000at least one suitable embryo to transfer (p = 0.02; OR 1.18; 95% CI
1.02–1.36) (Fig. 8). The area under the ROC curve was 0.85. The
effect of the number of oocytes on the number of suitable embryos
to transfer was signiﬁcant (p = 0.02, IRR 1.05;95%CI 1.01–1.10). The
number of blastocysts biopsied was also a signiﬁcant predictor of
the odds of at least one suitable embryo to transfer (p = 0.007; OR
1.59; 95% CI 1.13–2.24) (Fig. 9).
In contrast, the total number of oocytes collected was not
signiﬁcantly associated with the odds of a live birth (p = 0.09; OR
1.10; 95% CI 0.99–1.23) (Fig.10). The number of blastocysts biopsied
(p = 0.03; OR 1.22; 95% CI 1.02–1.47) and the number of suitable
embryos to transfer had a signiﬁcant effect on the odds of a live
birth (p = 0.002; OR 3.23; 95% CI 1.54–6.80) (Fig. 11).
Conclusions
This study has demonstrated that the live birth following PGT-
M and PGT-SR is signiﬁcantly associated with the numbers of
oocytes collected, blastocysts biopsied and suitable embryos to
transfer. This is the ﬁrst study which assesses these parameters in
the context of PGT-M and PGT-SR outcome following blastocyst
biopsy, vitriﬁcation and frozen embryo transfer.
The positive association between oocyte yield and live birth
outcome in fresh and frozen IVF cycles has been well established
[1,13]. Following analysis of >400, 0000 IVF cycles, Sunkara et al.
(2011) demonstrated a strong association between the number of
oocytes retrieved and live birth rate, where it increased with number
of oocytes up to 15, plateaued between 15 and 20 and steadily
declined beyond 20 oocytes [1]. Oocyte yield is also an important
predictor for successful PGT outcome. In this study, there was a
signiﬁcant relationship between oocyte yield, number of blastocysts
biopsied and suitable embryos to transfer in the whole group
analysis. In this model, if age increases by one year, the number of
blastocysts for biopsy and suitable embryos to transfer decreases by
2% and 6%, respectively. The area under the ROC curve indicated the
number of oocytes collected was a good predictor for both number of
blastocysts biopsied and suitable embryos to transfer. The number of
oocytes retrieved was also signiﬁcantly associated with the
probability of a live birth. As the number of oocytes increased by
one, there is a 6% increase in the odds of a live birth.
Similar to this study, Vandervorst et al. (1998) also demon-
strated a positive correlation between number of oocytes retrieved
and number of embryos biopsied [2]. Although embryo biopsy was
carried out on day-3 and fresh transfer was undertaken, there was
a signiﬁcant correlation between the group where < 9 oocytes
were retrieved and  9 oocytes with respect to number of embryos
biopsied, number of embryos transferred and number of cycles
resulting in embryo transfer.
In the current study, the number of blastocysts biopsied has a
signiﬁcant impact on the number of suitable embryos to transfer. For
eachadditionalblastocystbiopsied,thereisa61%increaseinlikelihood
of having a suitable embryo to transfer with a predictive power of 0.8.
Moreover, for each additional suitable embryo to transfer, the live birth
increases by 38% with a ROC curve of 0.71. Thus, the number of
blastocysts biopsied as well as the number of suitable embryos to
transfer has a moderate-high predictive power on PGT outcome.
Further sub-analysis of couples embarking on PGT for single
gene and chromosomal rearrangement also showed signiﬁcant
correlations between oocyte yield, number of blastocysts biopsied,
number of suitable embryos to transfer and odds of a live birth. For
each additional suitable embryo to transfer, there is a 1.28- and
3.23-fold increase in the odds of a live birth for single gene and
chromosomal rearrangement, respectively.
The live birth rate following blastocyst biopsy, vitriﬁcation and
frozen embryo transfer was 53% in our study, which is higher than
that reported by ESHRE consortium XIV-XV of 25% [14]. The higherassociated with oocyte yield and number of biopsied and suitable
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study, which was only carried out in 4% of the PGT cycles reported
to the ESHRE consortium. Furthermore, aneuploidy testing was
also carried out in this study which showed that approximately a
third of the embryos were aneuploid even when they were
genetically suitable for transfer.
Some couples seeking PGT have diminished ovarian reserve and
were counselled about the risk of poor response to stimulation and
high risk of cancellation. For some couples, embryo batching was
carried out to maximise egg yield, number of blastocysts to biopsy
and eventually a suitable embryo to transfer. By extrapolating the
results of this study, the probability of live birth can be determined
from the number of oocytes collected and number of blastocysts
biopsied. This can assist reproductive medicine specialists in
counselling patients and enhances couple’s ability to make fully
informed decision about whether to continue with further embryo
batching cycles or proceed with genetic analysis. In the whole
group analysis, if 10 oocytes are retrieved, the live birth rate was
approximately 40%. The probability of a live birth is~65% when four
suitable embryos are available to transfer and decreases to just
under 50% when two suitable embryos are available to transfer.
Limitations of this study include its retrospective design and
the nature of obtaining data from a single centre. We have
demonstrated that a surrogate of a suitable embryo to transfer is
egg yield and thus patients should be stimulated with a higher
dose and/or in an aggressive step up protocol than for standard IVF
patients in order to maximise egg and number of blastocysts to
biopsy. Given that most PGT centres have adopted blastocyst
biopsy and freeze protocols, a more aggressive stimulation
approach can be adopted owing to the reduced risk of ovarian
hyper stimulation syndrome associated with frozen cycles. We
demonstrate herein a clear relationship between PGT outcome and
ovarian response determined by the number of oocytes retrieved,
blastocysts to biopsy and suitable embryos to transfer.
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